Zejing Pharmaceuticals: Products under development are recognized as orphan drug by the US FDA_New Third Board News_New Third Board Market_中金在线 | China Business Blog

Aggregated China Business Blogs

2020-12-17

Zejing Pharmaceuticals: Products under development are recognized as orphan drug by the US FDA_New Third Board News_New Third Board Market_中金在线

Aggregated Source: Caishen.Co

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Original URL: Click here to visit original article
Copyright Caishen.Co